Head of Investor Relations
Cecilia Ketels
cecilia.ketels@elekta.com
Q1 presentation
for investors and analysts
at 10 am Aug 24
Link to webcast:
Phone numbers:
Sweden: +46 (0) 8 5051 0031
UK: +44 (0) 207 107 06 13
USA: +1 (1) 631 570 56 13
Press
releases
September 14
Elekta Foundation raises USD 50,000 for women with advanced-stage cervical cancer with “Ride4Rwanda” cycling challenge
August 29
Elekta and the International Atomic Energy Agency (IAEA) partner to improve access to cancer care in underserved countries
August 24
Report from the Annual General Meeting 2023 in Elekta
Upcoming
events
Q2 report
Silent period prior to Q2 report
Road show Munich
BofA Global Healthcare conference, London
KeplerChevreux Autumn conference, Paris
Morgan Stanley Healthcare conference, New York
Goldman Sachs Healthcare Conference, London
Carnegie Mid-cap conference, Stockholm
Annual General Meeting 2023
Q1 report
Silent period prior to Q1
JP Morgan European Healthcare Conference
Capital Markets Day 2023
Q4 report
Silent period prior to Q4 report
Jefferies pan-european mid-cap conference
Carnegie Healthcare Seminar, Stockholm
Payment date for proposed dividend
Record date for proposed dividend
Q3 report
Silent period prior to Q3 report
SEB Nordic Seminar, Copenhagen
J.P. Morgan Healthcare Conference, San Francisco
DNB Nordic Healthcare Conference, Oslo
Berenberg European Conference, Surrey/UK
BNP Paribas Exane DILS CEO Conference (digital)
Q2 roadshow, London, Carnegie
Q2 roadshow, Stockholm, SEB
Q2 report
Silent period prior to Q2 report
BofA Global Healthcare Conference, London
Morgan Stanley Global Healthcare Conference, New York
J.P. Morgan European Healthcare CEO Conference Call (digital)
Pareto Securities' Healthcare Conference, Stockholm
Goldman Sachs Medtech and Healthcare Conference, London
Payment date for proposed dividend
Record date for proposed dividend
Q1 roadshow, London, Jefferies (digital)
Annual General Meeting 2022
Q1 roadshow, Stockholm, SEB
Q1 report
Silent period prior to Q1 report
Annual Report 2021/22
Q4 roadshow, London
Q4 roadshow, Stockholm
Q4 and year-end report
ESTRO investor meeting, Copenhangen
Silent period prior to Q4 report
Jefferies Pan-European Mid-Cap Conference (virtual)
Oppenheim healthcare conference
Carnegie Nordic healthcare conference
Q3 roadshow, London
Q3 roadshow, US (digital)
Q3 roadshow, Stockholm
Q3 report
Silent period prior to Q3 report
JP Morgan healthcare conference (digital)
SEB Nordic seminar (digital)
Berenberg Conference (digital)
Danske Bank winter conference (digital)
Q2 road show, London (digital)
Q2 roadshow, Stockholm
Q2 report
Silent period prior to Q2 report
Q1 Report
We continued the improving trend from the previous quarters and began our fiscal year with strong performance. We gained market shares and converted a strong order backlog resulting in good revenue growth and strong margin expansion.
Gustaf Salford, President and CEO
2023-08-24Interim report, May - July 2023/24
Key figures (rolling 12m)
Annual Report
2023-07-07 Annual Report 2022/23
Subscribe to press releases
